| Based on recent diminished order flow resulting from lower than anticipated customer demand for the remainder of 2009, in both orthopaedic and non-orthopaedic markets, Symmetry is adjusting its previously stated annual revenue guidance to a range of $355M-$365M, from $385M-$405M. The company now expects full year 2009 earnings per share to be in the range of 63c-68c per diluted share, as opposed to the previously announced range of 77c-85c. Consensus is for revenue of $391.28M and EPS of 80c. :theflyonthewall.com |
